Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163710 | SCV000214284 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000988090 | SCV000259578 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2024-12-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000733019 | SCV000727878 | likely benign | not provided | 2019-07-22 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733019 | SCV000861031 | uncertain significance | not provided | 2018-05-17 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988090 | SCV001137670 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000988090 | SCV002045990 | likely benign | Microcephaly, normal intelligence and immunodeficiency | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163710 | SCV002536577 | likely benign | Hereditary cancer-predisposing syndrome | 2022-01-12 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000733019 | SCV004222116 | likely benign | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003975231 | SCV004798287 | likely benign | NBN-related disorder | 2021-12-24 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |